Rise in Diabetes

It is no secret that the incidence of diabetes is on the rise both in the United States and around the world. According to recent statistics, current trends estimate the prevalence of diabetes in the US will increase from 14% of the population to 33% by the year 2050.1 Between 15-25% of people with diabetes will develop foot and leg ulcers at some point.2 Diabetic foot ulcers are the leading cause of hospitalization among diabetic patients and often lead to amputations. An uncomplicated diabetic foot ulcer is estimated to cost $8000 to treat.3 Diabetes-related amputations cost approximately $3 billion dollars per year4 and approximately 85% of all lower extremity amputations are preceded by a diabetic ulcer. 5 Simply put, diabetic wounds cost the US health care system billions of dollars each year.


Management of these wounds is of the utmost importance, both in terms of patient quality of life and cost containment. CellerateRX® is a patented form of collagen that has been shown to be effective in managing diabetic wounds in multiple clinical applications and settings. In one evidence based study at a major wound care center in the northeast, the CellerateRX® treated wounds were healed by five (5) weeks while the control wound were approximately 80% healed at twelve (12) weeks. 1 These results were accomplished with once or twice a week application. This is significant both in terms of patient compliance and cost containment.


  1. Web MD 2010

  2. Archive for the "Diabetic Skin Ulcers" April 2010

  3. "Health Economic Implications for Wound Care and Limb Preservation," Dr. Driver, Dr. deLeon, Journal of Managed Care, Volume 11.

  4. Amputee Coalition of America/National Limb Loss Information Center Fact Sheet 2008

  5. Johns Hopkins Point of Care Information Center August 2010

  6. "Activated Collagen: An Evidence Based Study in Human Leg Ulcers", Dr. Matthew Regulski, SAWC 2009
CellerateRX Product Shot

CellerateRX® powder and gel form allows for no waste of product and is biocompatible and may used with any secondary dressing. It is biodegradable and does not need to be removed from the wound with subsequent dressing applications which is important as it provides:

  1. Less time on dressing changes
  2. Reduces patient discomfort
  3. Less manipulation of wound bed and
  4. Reduces potential for scarring

The powder and gel are ideal for tunneled/undermining wounds and skin flaps or tears.


CellerateRX® provides for quality outcomes in a cost effective manner. Cost containment measures include:

  1. 2-3x week application
  2. Effective with even less costly secondary dressings
  3. No waste of product
  4. Easy to use and requires less time for dressing applications

Its ease of application makes it ideal for home health or for those patients who take care of their own wounds as noted by Rhonda Surgnier who said, "My mother had a venous stasis ulcer on her inner ankle for over a year that we aggressively treated in order to heal. We used a variety of treatments including wet to dry, Silvadene®, Unna Boot and DuoDerm® dressings, none of which made any improvement. We began using the CellerateRX® and within a month the ulcer had almost completely healed. The advantages of the CellerateRX®, in addition to healing the ulcer, it provided pain relief and decreased our dressing supply cost. The product was so easy to use that she was able to perform her own wound dressings. The results that the CellerateRX® produced in such a short period of time were amazing."




Click Here to Download a PDF on the Rise in Diabetes


CellerateRX Saves MoneyOrder your trial TodayEvidence of CellerateRX Success

The Science

Testimonials

Evidence

Gel

Powder

Training and Videos

White Papers

FAQ

What is Collagen?

Information for your Doctor

Diabetic Ulcers

Ulcers due to Arterial Insufficiency

Pressure Ulcers

Surgical Wounds

Burns

Traumatic Wounds

Venous Stasis Ulcers

Superficial Wounds

Company Profile

Management

WCI Newsletter

Events

Contact Us

WMGTech.com

Press Release

Investors Information

In The News





Get Social

facebooktwitterlinkdinyou tube